Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (60%) |
| §102 only | 1 (20%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCINTOSH III, TRAVISS C | 1 | 73.3% | +13.9% |
| KIFLE, BRUCK | 1 | 79.2% | +15.9% |
| HUANG, RYAN | 1 | 51.8% | +32.2% |
| ROYCE, LIAM A | 1 | 65.0% | +21.8% |
| MOTEVALLI, OROD | 1 | — | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18007960 | Azirine Containing Compounds as Anti-Angiogenesis Agents and a Process for the Preparation Thereof | KIFLE, BRUCK | 120d overdue |
| 18022855 | PROCESS FOR THE DIRECT CONVERSION OF CELLULOSE TO GLYCOLS USING NON-NOBLE METAL LOADED ZEOLITE CATALYSTS | MCINTOSH III, TRAVISS C | 20d |
| 17788768 | HIGHLY PERMEABLE ULTRATHIN POLYMER NANOFILM COMPOSITE MEMBRANE AND A PROCESS FOR PREPARATION THEREOF | ROYCE, LIAM A | 29d |
| 17789357 | HIGHLY SELECTIVE ULTRATHIN POLYMER NANOFILM COMPOSITE MEMBRANE AND PROCESS FOR PREPARATION THEREOF | HUANG, RYAN | 34d |
| Art Unit | Apps |
|---|---|
| 1777 | 2 |
| 1693 | 1 |
| 1624 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18022855 | PROCESS FOR THE DIRECT CONVERSION OF CELLULOSE TO GLYCOLS USING NON-NOBLE METAL LOADED ZEOLITE CATALYSTS | MCINTOSH III, TRAVISS C | 1693 | §103 | Non-Final OA | 20d | Pending | Feb 23, 2023 |
| 18007960 | Azirine Containing Compounds as Anti-Angiogenesis Agents and a Process for the Preparation Thereof | KIFLE, BRUCK | 1624 | §102 | Non-Final OA | 120d overdue | Pending | Dec 02, 2022 |
| 17789357 | HIGHLY SELECTIVE ULTRATHIN POLYMER NANOFILM COMPOSITE MEMBRANE AND PROCESS FOR PREPARATION THEREOF | HUANG, RYAN | 1777 | §103 | Non-Final OA | 34d | Pending | Jun 27, 2022 |
| 17788768 | HIGHLY PERMEABLE ULTRATHIN POLYMER NANOFILM COMPOSITE MEMBRANE AND A PROCESS FOR PREPARATION THEREOF | ROYCE, LIAM A | 1777 | §103 | Final Rejection | 29d | Pending | Jun 24, 2022 |
| 17755556 | ANTI-INFLAMMATORY COMPOUNDS FOR USE IN THE TREATMENT OF DERMAL DISORDERS | MOTEVALLI, OROD | 1628 | Other | Non-Final OA | 27d | Pending | May 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial